Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Thera (NQ: VKTX )

50.86 -2.47 (-4.63%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,937,639
Open 54.15
Bid (Size) 50.33 (1)
Ask (Size) 50.79 (3)
Prev. Close 53.33
Today's Range 50.00 - 54.59
52wk Range 8.280 - 99.41
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
Via Benzinga
3 Unstoppable Stocks to Buy in August
It's not hard to envision how all three of these stocks can deliver exceptional growth. 
Via The Motley Fool

Performance

YTD
+178.23%
+178.23%
1 Month
-0.29%
-0.29%
3 Month
-36.11%
-36.11%
6 Month
+106.66%
+106.66%
1 Year
+300.16%
+300.16%

More News

Read More
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
Via The Motley Fool
What Are the Hottest Weight Loss Stocks Right Now? 3 Top Picks.
Via InvestorPlace
8 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Viking Therapeutics's Options: A Look at What the Big Money is Thinking
Via Benzinga
Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Better Weight Loss Drug Stock: Viking Therapeutics vs. Zealand Pharma
Via The Motley Fool
3 Overlooked Stocks Poised for a Breakout Very Soon
Via InvestorPlace
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why.
Via The Motley Fool
Topics Economy
Exposures Interest Rates
The Bull Case for Viking Therapeutics Just Got Even Stronger. Here's Why You Should Buy It.
Via The Motley Fool
Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia.
Via The Motley Fool
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
Via Benzinga
Is Viking Therapeutics a Millionaire-Maker Stock?
Via The Motley Fool
Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review
Via Investor's Business Daily
Why Weight Loss Drug Developer Stocks Tumbled on Thursday
Via The Motley Fool
Novo Nordisk Shares Decline Amid Competitive Pressure
Via Benzinga
Gold Down 2.5%; Northrop Grumman Posts Upbeat Earnings
Via Benzinga
Viking Therapeutics Stock Surges As Company Advances Weight Loss Drug To Late-Stage Trial: What Investors Need To Know
Via Benzinga
Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
Via Benzinga
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Why Eli Lilly and Company Shares Are Moving Lower On Thursday
Via Benzinga
Viking Therapeutics: Pharma Stock Soars on Positive Earnings
Via MarketBeat
Topics Earnings
Exposures Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.